Biocept Launches Liquid Biopsy Kits Intended to Broaden Use of its Proprietary Technology Platform for High Sensitivity Detection of Circulating Tumor DNA

Target Selector™ kits are research-use-only (RUO) and designed to enable laboratories around the world to leverage Biocept's patented assay technology to perform cutting-edge liquid biopsy testing SAN DIEGO, Jan. 28, 2019 -- (Healthcare Sales & Marketin... Diagnostics, Oncology, Product Launch Biocept, liquid biopsy, Target Selector, circulating tumor DNA
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news